Insulin lispro reduces insulin antibodies in a patient with type 2 diabetes with immunological insulin resistance

Diabetes Research and Clinical Practice

Volumn 61, Issue 2, 2003, Pages 89-92

  Asai, Mahito ^a   Kodera, Tutomu ^b   Ishizeki, Kanaki ^a   Uebori, Seiji ^a   Kashiwaya, Tagui ^a   Itoh, Hiroshi ^a   Makino, Isao ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Immunological insulin resistance; Insulin antibodies; Insulin lispro

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN ANTIBODY; INSULIN LISPRO; ISOPHANE INSULIN; PENFIL N; PENFIL R; UNCLASSIFIED DRUG;

ADULT; ANNULOPLASTY; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIET THERAPY; DOSE CALCULATION; FEMALE; HUMAN; IMMUNOGENICITY; INSULIN RESISTANCE; KIDNEY DISEASE; METABOLIC REGULATION; MITRAL VALVE REGURGITATION; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; RETINOPATHY;

EID: 0042889348     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(03)00105-0     Document Type: Article

References (6)

1. B29-insulin: dissociation of a protein-ligand complex. Protein Science. 5:1996;2521-2531.
2. Fineberg N.S., Fineberg S.E., Anderson J.H., Birkett M.A., Gibson R.G., Hufferd S. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes. 45:1996;1750-1754.
3. Jovanovic L., Ilic S., Pettitt D.J., et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care. 22:1999;1422-1427.
4. Lahatela J.T., Knip M., Paul R., Antonen J., Salmi J. Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. Diabetes Care. 20:1997;71-73.
5. Kumar D. Lispro analog for treatment of generalized allergy to human insulin. Diabetes Care. 20:1997;1357-1359.
6. Plank J., Semlitsch B., Wutte A., et al. A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes. Diabetes Care. 25:2002;2053-2057.